The pre-conditioning incidence of antiphospholipid antibodies is not significantly increased in patients with bone marrow transplant-related organ dysfunction.
Hepatic dysfunction resulting from hepatic veno-occlusive disease (VOD) is a common complication of bone marrow transplantation (BMT). Some investigators believe that hepatic dysfunction, along with pulmonary and central nervous system (CNS) dysfunction, is part of a systemic disorder called multiple organ dysfunction syndrome (MODS). Endothelial damage by pretransplant chemo-radiation and activation of hemostasis are considered early events in the development of hepatic VOD. The pathological mechanism leading to fibrous obliteration of hepatic vessels may also take place in pulmonary and CNS vessels. Since antiphospholipid antibodies (aPA) are associated with venous and arterial thrombosis, which can lead to vessel occlusion, we asked if the incidence of aPA before conditioning was greater in patients who developed MODS following BMT. Samples drawn before pretransplant chemo-radiation from 57 patients who subsequently developed MODS and 55 control patients who did not develop MODS were studied blindly for aPA by ELISA. The number of aPA-positive patients who developed MODS (10/57), compared to the number of aPA-positive patient controls who did not develop MODS (7/55) was not statistically significant (P = 0.48). Our data indicate that the incidence of aPA before conditioning was not greater in patients who developed MODS, including hepatic VOD, following BMT.
Fastenau
D R
DR
Methodist Hospital, Indianapolis, IN 46202, USA.
Haire
W D
WD
Schneider
J R
JR
Stephens
L C
LC
Faulk
W P
WP
McIntyre
J A
JA
D017152:Antibodies, Antiphospholipid / Q000097:blood*; D015551:Autoimmunity; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009102:Multiple Organ Failure / Q000097:blood / Q000209:etiology / Q000276:immunology*
D017152:Antibodies, Antiphospholipid